Pharming Group NV
AEX:PHARM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pharming Group NV
AEX:PHARM
|
NL |
Wall St Price Targets
PHARM Price Targets Summary
Pharming Group NV
According to Wall Street analysts, the average 1-year price target for PHARM is 2.2568 EUR with a low forecast of 1.818 EUR and a high forecast of 2.73 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PHARM's stock price target?
Price Target
2.2568
EUR
According to Wall Street analysts, the average 1-year price target for PHARM is 2.2568 EUR with a low forecast of 1.818 EUR and a high forecast of 2.73 EUR.
What is the Revenue forecast for Pharming Group NV?
Projected CAGR
17%
Over the last 14 years, the compound annual growth rate for Revenue has been 41%. The projected CAGR for the next 5 years is 17%.
What is the Operating Income forecast for Pharming Group NV?
Projected CAGR
35%
The compound annual growth rate for Operating Income over the next 5 years is 35%.
What is the Net Income forecast for Pharming Group NV?
Projected CAGR
130%
The compound annual growth rate for Net Income over the next 4 years is 130%.
